Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 699 of 1,261

  1. US 9314507

    Methods of treatment of heart failure with natriuretic peptides

    Capricor Therapeutics, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  2. US 9314494

    Cranberry xyloglucan oligosaccharide composition

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  3. US 9314488

    Cellular extracts

    REGENICS AS · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  4. US 9314469

    Method for treating neurocognitive dysfunction

    TONIX PHARMA LIMITED · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  5. US 9314477

    Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof

    RedHill Biopharma Ltd. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  6. US 9314465

    Drug combinations and uses in treating a coughing condition

    Infirst Healthcare Limited · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  7. US 9314456

    Antibacterial compounds

    SUMMIT THERAPEUTICS PLC · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  8. US 9314455

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  9. US 9314448

    Method of inhibiting ABCG2 and other treatment methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  10. US 9314463

    Oligomer-diarylpiperazine conjugates

    Nektar Therapeutics · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  11. US 9309232

    Synthesis of novel inhibitors of isoprenoid biosynthesis

    Beryllium Discovery Corp. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  12. US 9310368

    High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  13. US 9309535

    Combination anti-HIV vectors, targeting vectors, and methods of use

    The Regents of the University of California · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  14. US 9309326

    Readily isolated bispecific antibodies with native immunoglobulin format

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  15. US 9309553

    Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  16. US 9310365

    Method of diagnosing and treating melioidosis

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  17. US 9309298

    Anti-bacterial polypeptides and pathogen specific synthetic antibodies

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  18. US 9309250

    Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  19. US 9309235

    SGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  20. US 9309206

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  21. US 9308273

    Polymer derivatives comprising an acetal or ketal branching point

    Nektar Therapeutics · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  22. US 9308256

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  23. US 9308249

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  24. US 9309187

    EP2 receptor agonists

    TAKEDA GMBH · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.